- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01500746
Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds (PLI2)
March 10, 2014 updated by: Robert Galiano, Northwestern University
Bedside Pulse Lavage Irrigation Project
This study evaluates the effectiveness of pulse lavage therapy in decreasing bacterial counts in chronic wounds.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pulse lavage irrigation is an effective method of cleaning both acute and chronic wounds.
The major drawback to pulse irrigation is that it is extremely messy and can easily contaminate the patient's surroundings, putting other patients and the person operating the device at risk.
In order to obtain the benefits of pulse lavage, we have created a device that will contain the water spray from the lavage and protect both the patient and their surroundings.
Due to the fact that frequent (multiple times daily) pulse lavage therapy has not been possible previously, it is unknown how effectively serial pulse lavage irrigation reduces bacterial counts.
This study evaluates the effectiveness of serial pulse lavage therapy in decreasing bacterial counts in chronic wounds.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients must have a chronic wound (as defined by the wound being present for >30 days) located on any part of their body
- The wound must be smaller than 10cm in greatest diameter.
- Patients must have an expected remaining hospital duration of 4 days
- Patients must be willing and able to comply with all study procedures
Exclusion Criteria:
- Patients must not have undergone any surgical excisions or debridements of the wound in the past 30 days
- The wound may not undergo any surgical procedures or other treatments other than the study treatments during the course of the study.
- The wound may not require any immediate surgical intervention or debridement
- Patients may not start any new antibiotic therapy during the course of the study
- Must not have an allergy to skin adhesives.
- Patients must not be taking any immunosuppressive medications.
- Subjects who, in the opinion of the investigator, may not complete the study for any reason.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lavage arm
This group will serve as the experimental arm.
They will undergo twice daily pulse lavage of their wounds for 4 days.
In between the lavage treatments, their wounds will be dressed with moist gauze.
|
A pulse lavage machine will be used to irrigate the wound with a total of 4 liters of water, twice daily, for a total of 4 days (8 treatments).
Other Names:
|
|
Active Comparator: Moist dressings
This group will serve as the control group.
They will undergo twice daily dressing changes with moist gauze dressings for a total of 4 days (8 dressing changes).
Bacterial counts and gene expression analysis will be performed prior to the first dressing change and after the last dressing change.
|
Wounds will be treated with moist gauze dressing changes twice daily for a total of 4 days (8 treatments).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Bacterial Counts
Time Frame: Baseline and at 4 days
|
A punch biopsy of the wound will be taken once the subject is enrolled in the study.
A repeat biopsy will be taken after the 8th lavage treatment or the 8th dressing change.
These will be sent for bacterial count analysis and the difference in bacterial counts will be evaluated.
The lavage fluid from baseline measurements will be filtered and sent for bacterial counts and will be compared to the filtered fluid from the last lavage treatment.
In addition, surface swabs will be taken at the beginning and end of the study and will be sent for bacterial counts as well.
Bacterial counts from these lavage, biopsy specimen, and swabs will be averaged and analyzed.
|
Baseline and at 4 days
|
|
Change in Gene Expression Analysis
Time Frame: 4 days
|
A punch biopsy will be taken at the beginning of the study.
this will be sent for gene expression analysis.
A repeat biopsy at the end of the study will also be sent at the end of the study, and a change in gene expression in analysis will be evaluated.
|
4 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain With Lavage Treatments
Time Frame: 4 days
|
After each lavage treatment, the subjects will complete a visual analogue scale that will determine the level of discomfort that they experienced during the study.
|
4 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert D Galiano, MD, Northwestern University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Brown LL, Shelton HT, Bornside GH, Cohn I Jr. Evaluation of wound irrigation by pulsatile jet and conventional methods. Ann Surg. 1978 Feb;187(2):170-3. doi: 10.1097/00000658-197802000-00013.
- Granick MS, Tenenhaus M, Knox KR, Ulm JP. Comparison of wound irrigation and tangential hydrodissection in bacterial clearance of contaminated wounds: results of a randomized, controlled clinical study. Ostomy Wound Manage. 2007 Apr;53(4):64-6, 68-70, 72.
- Kuehn BM. Chronic wound care guidelines issued. JAMA. 2007 Mar 7;297(9):938-9. doi: 10.1001/jama.297.9.938. No abstract available.
- Svoboda SJ, Bice TG, Gooden HA, Brooks DE, Thomas DB, Wenke JC. Comparison of bulb syringe and pulsed lavage irrigation with use of a bioluminescent musculoskeletal wound model. J Bone Joint Surg Am. 2006 Oct;88(10):2167-74. doi: 10.2106/JBJS.E.00248.
- Keblish DJ, DeMaio M. Early pulsatile lavage for the decontamination of combat wounds: historical review and point proposal. Mil Med. 1998 Dec;163(12):844-6.
- Luedtke-Hoffmann KA, Schafer DS. Pulsed lavage in wound cleansing. Phys Ther. 2000 Mar;80(3):292-300. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
December 23, 2011
First Submitted That Met QC Criteria
December 23, 2011
First Posted (Estimate)
December 28, 2011
Study Record Updates
Last Update Posted (Estimate)
April 14, 2014
Last Update Submitted That Met QC Criteria
March 10, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00057288
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Wounds
-
PEMF Systems, Inc.Southern California Institute for Research and Education; VA Long Beach Healthcare...Not yet recruitingChronic Wounds
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University Hospital, LillePixacareNot yet recruiting
-
SerenaGroup, Inc.MDM Wound Ventures, LLCCompletedChronic Wounds | Acute WoundsUnited States
-
SerenaGroup, Inc.Anacapa Technologies IncCompleted
-
Woundchek Laboratories BVInnovate UK; Pennine Care NHS Foundation Trust; Greater Manchester Academic Health...Completed
-
Smith & Nephew, Inc.CompletedChronic WoundsUnited Kingdom
-
Lohmann & RauscherRecruitingAcute and Chronic WoundsGermany
-
StimLabsActive, not recruitingChronic Wounds | Diabetic UlcersUnited States
-
University Hospital Center of MartiniqueNot yet recruitingChronic WoundsMartinique
Clinical Trials on Pulse lavage treatment
-
The Metis FoundationUnited States Army Institute of Surgical ResearchCompletedHypertrophic ScarUnited States
-
The University of Hong KongStorz Medical AGRecruitingMild Neurocognitive DisorderHong Kong
-
US Department of Veterans AffairsCompleted
-
Kinamed IncorporatedUS Department of Veterans AffairsCompletedPostoperative Complications | Memory DisordersUnited States
-
University of ValenciaCompletedSubarachnoid Hemorrhage, Aneurysmal | Hydrocephalus | Vasospasm, CerebralSpain
-
SolitonUnited States Naval Medical Center, San DiegoCompletedScars, HypertrophicUnited States
-
Sheba Medical CenterRabin Medical Center; Meir Medical Center; Shaare Zedek Medical CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Serous Cystadenocarcinoma | Primary Peritoneal CarcinomaIsrael
-
The Children's Hospital of Zhejiang University...Shanghai Feihong Medical Technology Co., Ltd.; Zhuhai Huaguang Medical Technology...Not yet recruiting
-
Prelife KftCompletedInfertility, Female | IVF
-
The First People's Hospital of ZunyiCompletedDysphagia | Stroke Associated Pneumonia | Non Severe Ischemic StrokeChina